Form 8-K - Current report:
SEC Accession No. 0001493152-26-018725
Filing Date
2026-04-23
Accepted
2026-04-23 16:30:37
Documents
16
Period of Report
2026-04-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 48496
2 EX-1.1 ex1-1.htm EX-1.1 237129
3 EX-5.1 ex5-1.htm EX-5.1 11075
4 EX-99.1 ex99-1.htm EX-99.1 12800
5 GRAPHIC ex5-1_001.jpg GRAPHIC 5137
6 GRAPHIC ex99-1_001.jpg GRAPHIC 10445
  Complete submission text file 0001493152-26-018725.txt   561005

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE lucd-20260423.xsd EX-101.SCH 3038
8 XBRL LABEL FILE lucd-20260423_lab.xml EX-101.LAB 34239
9 XBRL PRESENTATION FILE lucd-20260423_pre.xml EX-101.PRE 22374
19 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3339
Mailing Address 360 MADISON AVENUE 25TH FLOOR NEW YORK NY 10017
Business Address 360 MADISON AVENUE 25TH FLOOR NEW YORK NY 10017 212 949 4319
Lucid Diagnostics Inc. (Filer) CIK: 0001799011 (see all company filings)

EIN.: 825488042 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40901 | Film No.: 26889105
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)